2230 · 03/11/2019 08:10:22 · Announcement #56588 · View on Saudi Exchange

Saudi Chemical Co. announces its Interim Financial Results for the Period Ending on 2019-09-30 ( Nine Months )

Element ListCurrent QuarterSimilar quarter for previous year%ChangePrevious Quarter% Change
Sales/Revenue 739.8630.817.279778.4-4.958
Gross Profit (Loss) 10984.229.453119.8-9.015
Operational Profit (Loss) 35.42826.42849.3-28.194
Net Profit (Loss) after Zakat and Tax 13.413.5-0.7430.9-56.634
Total Comprehensive Income 13.413.5-0.7430.9-56.634
All figures are in (Millions) Saudi Arabia, Riyals
Element ListCurrent PeriodSimilar period for previous year%Change
Sales/Revenue 2,360.52,075.813.715
Gross Profit (Loss) 343.1299.314.634
Operational Profit (Loss) 142.2138.12.968
Net Profit (Loss) after Zakat and Tax 83.697.7-14.431
Total Comprehensive Income 83.697.7-14.431
Total Share Holders Equity (after Deducting Minority Equity) 1,606.11,522.55.49
Profit (Loss) per Share 1.31.55
All figures are in (Millions) Saudi Arabia, Riyals
Element ListExplanation
Increase (Decrease) in Net Profit for Current Quarter Compared to the Same Quarter of the Previous Year is Attributed to The slight decrease in net profit is mainly due to the increase in the operational expenses, finance costs and zakat provision, in which on the other hand, the sales are increased.
Increase (Decrease) in Net Profit for Current Quarter Compared to the Previous Quarter is Attributed to The decrease in net profit is mainly due to the decrease in sales and also due to the increase in the provision for doubtful debts, finance costs and zakat provision.
Increase (Decrease) in Net Profit for Current Period Compared to the Similar Period of the Previous Year is Attributed to The decrease in net profit is mainly due to the commencement of commercial production of two production lines of AJA's plant (subsidiary company) and charging all costs of the production of the two lines to income statement for the period. It is expected to cover such costs gradually through the increase in sales. In addition, to the increase in operational expenses (mainly relating to pharmaceutical sector due to the increase in sales of distributing medicines), the increase in finance costs and zakat provision.
Basis of the External Auditor's Opinion Unmodified opinion
Reclassification of Comparison Items Certain figures of comparatives have been reclassified to confirm to the current presentation.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.